Leonteq Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.62M Buy
126,855
+59,164
+87% +$1.57M 0.15% 110
2026
Q2
$1.63M Sell
67,691
-54,710
-45% -$1.43M 0.06% 199
2026
Q1
$3.44M Sell
122,401
-633,016
-84% -$16.9M 0.13% 131
2025
Q4
$18.8M Buy
755,417
+295,029
+64% +$7.44M 0.57% 30
2025
Q3
$11.7M Sell
460,388
-621,569
-57% -$15.3M 0.36% 50
2025
Q2
$26.2M Buy
1,081,957
+616,025
+132% +$14.4M 1.01% 20
2025
Q1
$11.8M Buy
465,932
+25,576
+6% +$669K 0.67% 21
2024
Q4
$11.7M Sell
440,356
-33,767
-7% -$916K 0.79% 21
2024
Q3
$13.7M Buy
474,123
+102,180
+27% +$2.98M 1.04% 16
2024
Q2
$10.4M Buy
371,943
+291,881
+365% +$8.04M 0.74% 22
2024
Q1
$2.22M Sell
80,062
-370,202
-82% -$10.3M 0.17% 139
2023
Q4
$13M Buy
450,264
+326,169
+263% +$9.9M 0.74% 32
2023
Q3
$4.12M Sell
124,095
-177,701
-59% -$6.28M 0.23% 97
2023
Q2
$11.1M Buy
301,796
+292,503
+3,148% +$11.4M 0.57% 43
2023
Q1
$379K Sell
9,293
-140,932
-94% -$6.09M 0.02% 419
2022
Q4
$7.7M Sell
150,225
-21,971
-13% -$1.05M 0.29% 61
2022
Q3
$7.54M Buy
172,196
+83,680
+95% +$4.07M 0.29% 67
2022
Q2
$4.64M Sell
88,516
-17,702
-17% -$902K 0.17% 115
2022
Q1
$5.5M Sell
106,218
-121,545
-53% -$6.31M 0.2% 112
2021
Q4
$13.4M Buy
227,763
+197,431
+651% +$9.8M 0.48% 43
2021
Q3
$1.3M Sell
30,332
-136,197
-82% -$6.03M 0.06% 263
2021
Q2
$6.52M Sell
166,529
-112,161
-40% -$4.36M 0.39% 56
2021
Q1
$10.1M Sell
278,690
-22,429
-7% -$796K 0.6% 42
2020
Q4
$11.1M Buy
+301,119
New +$11M 0.59% 34

Other funds holding PFE

Leonteq Securities's PFE Position: Q3 2026 in Review

Leonteq Securities increased its Pfizer (PFE) stake by 87% in Q3 2026, buying an estimated $1.57M and bringing the position to 126,855 shares worth $3.62M. The position accounts for 0.15% of the portfolio, ranked #110.

Leonteq Securities first reported a position in PFE in Q4 2020 and has held it in 24 quarters since. The position peaked at $26.2M in Q2 2025. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Leonteq Securities held 126,855 shares of Pfizer worth $3.62M as of Q3 2026.
  • Leonteq Securities bought 59,164 Pfizer shares in Q3 2026, an estimated $1.57M.
  • Pfizer made up 0.15% of Leonteq Securities's portfolio in Q3 2026, its #110 holding.
  • Leonteq Securities first reported a position in Pfizer in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's Pfizer position peaked at $26.2M in Q2 2025.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.